Press Releases - 2022-03-29

Date	Title	Company
29-Mar-2022	Automated Molecular Diagnostics Testing System Market Key Drivers and Restraints, Opportunities, Industry Share & Trend Analysis Report to 2026	MARKITWIRED
29-Mar-2022	RECORDATI RARE DISEASES ANNOUNCE PUBLICATION IN THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM OF THE PHASE III LINC 4 STUDY CONFIRMING THE EFFICACY AND SAFETY OF ISTURISA® (OSILODROSTAT) IN PATIENTS WITH CUSHING’S DISEASE	Recordati Rare Diseases
29-Mar-2022	Amniotic Membranes Market is expected to expand at CAGR of 9.3% over 2018–2028, to surpass US$ 2,322 Million by 2028 end	MARKITWIRED
29-Mar-2022	Extremity Tissue Expanders Market is projected to increase at a 6.3% over the period of 2018-2028.	MARKITWIRED
29-Mar-2022	Sustained Release Excipients Market Kay Players – Roquette Freres S.A. Colorcon Inc., Ashland Global Holdings, BASF Corporation, The Dow Chemical Company	MARKITWIRED
29-Mar-2022	Endodontics And Orthodontics Market Key Players : FKG Dentaire SA, Ivoclar Vivadent Inc, sirona, inc., 3M, Align Technology, Inc, DENTAURUM GmbH & Co. KG	MARKITWIRED
29-Mar-2022	Angio Suites Market Key Players – Siemens AG, Shimadzu Corporation, Canon, Inc., GE Healthcare, Koninklijke Philips N.V.	MARKITWIRED
29-Mar-2022	Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver	Sanofi
29-Mar-2022	GreenBank Capital Portfolio Company CodiKoat Delivers Revolutionary Biosafety Product and Enters Into Partnerships	CodiKoat
29-Mar-2022	CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects	CD Formulation
29-Mar-2022	Telemedicine Market Size Worth Around US$ 186.7 Bn by 2027	Global Market Insights
29-Mar-2022	Accelerate Diagnostics Announces Launch Of Accelerate Arc™ Module and BC Kit	Accelerate Diagnostics
29-Mar-2022	EXACT Therapeutics AS Announces Appointment of Dr Per Walday as Chief Executive Officer	EXACT Therapeutics
29-Mar-2022	European Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B	CSL Behring
29-Mar-2022	Carthera’s SonoCloud technology demonstrates safety and therapeutic potential in clinical trial on patients living with Alzheimer’s Disease	Andrew Lloyd Associates
29-Mar-2022	Gadeta to Present Data on Tumor-Specific Cell Therapies at Leading Scientific Conferences	Gadeta
29-Mar-2022	Xenpozyme® (olipudase alfa) approved in Japan, first and only approved therapy indicated to treat acid sphingomyelinase deficiency	Sanofi
29-Mar-2022	DelSiTech Enters into an Exclusive Licensing Agreement with Optifye Therapeutics for the Development of a Controlled Release Ophthalmic Eye Drop Product	DelSiTech
29-Mar-2022	Novo Holdings reports Total Income and Returns of DKK 37 billion (€5 billion) in 2021, representing a 29% increase over 2020	Novo Holdings
29-Mar-2022	Oxurion to Participate in Needham Virtual Healthcare Conference	Oxurion